European medical booking platform DocPlanner has secured $20 million in Series C funding. Target Global led the round with participation from ENERN Investments and EBRD. Also, DocPlanner has merged with Spain-based rival Doctoralia. No financial terms were disclosed.
DocPlanner.com, an online booking platform for healthcare appointments, has raised a new funding round, pulling in $20 million in Series C financing led by Target Global. Also contributing to the round were ENERN Investments and EBRD. Additionally, the company will create the biggest online healthcare booking platform in the world by merging with Doctoralia.com, a Spain-based competitor. The funds will also finance expansion into other foreign markets and further the development of the company’s online practice management software solution.
DocPlanner is a marketplace and cloud software for private healthcare providers – including individual doctors, dentists and other healthcare professionals such as dietitians and psychologists, as well as small and large clinics. Doctors can use its services to manage their professional profile; follow and respond to opinions received from patients; offer an online calendar to their existing and new patients; and improve their office administration (via personal tele-assistant, automatic appointment reminders, etc.). The company currently operates websites in 25 countries and processes 200,000 bookings per month.
DocPlanner grabs $20 million for expansion
Fast growth, a strengthening leadership position in Europe and plans to expand into new geographies have convinced new investors to fund Docplanner further. In the recent Series C financing the company raised $20 million led by Target Global with participation by ENERN Investments and EBRD (via its Venture Capital Investment Programme).
DocPlanner’s total funding to date stands at $34 million. Previous investors include EBRD, Point Nine Capital, Piton Capital, RTAventures, Lukasz Gadowski (Delivery Hero) and Fabrice Grinda (Airbnb, Uber).
“We have the ambition to become the clear #1 global online platform for healthcare. The focus now is on building a stronger global presence – bolstering positions in key markets (Poland, Turkey and Italy) and adding 4-5 high growth markets, either through greenfield or acquisition. The presence and usefulness of healthcare platforms is slowly getting recognized by doctors and patients in a growing number of countries,” says Mariusz Gralewski, founder and CEO of DocPlanner. “In our key markets we are actively growing the supply of doctor calendars available to patients online and are focusing on delivering a top quality experience for both sets of users.”
“We are proud to become an investor in Docplanner. Our team was blown away by the market response to their unique product suite which provides better patient management, more sophisticated marketing and lead generation tools to doctors and clinics. We believe that DocPlanner’s ability to expand internationally by integrating local service providers will lead them to a position of market dominance,” commented Yaron Valler, General Partner at Target Global.
DocPlanner merges with Doctoralia
Over the past few years both companies have established strong presences in their core markets. Docplanner now attracts 8 million unique users monthly, with 90% coming from Europe. Doctoralia, with over 9 million unique users monthly, holds leading positions in Spain and Latin America, including Brazil and Mexico. The combined company will have 17 million unique users, paying clients in 20 markets and host the biggest database of doctors worldwide – 5 million healthcare professionals – and serve 3 million registered patient users.
“The companies have complementary geographies and great teams. By joining forces we can leverage best practices and provide an even better software and product offering for both doctors and patients on a truly global scale,” commented Mariusz Gralewski, founder and CEO of DocPlanner.
While the combined company will be majority-owned by former DocPlanner shareholders the existing Doctoralia founders will become significant shareholders and will join the senior management team. The Barcelona-based team will continue to strengthen the merged company’s presence in Spain and Latin America.
“We are thrilled to build a global healthcare leader with DocPlanner, especially that the teams share similar attitudes and there is so much we can learn from each other; we could not have asked for a better partner,” says Albert Armengol, founder and CEO of Doctoralia.
DocPlanner is one of the world’s biggest healthcare marketplaces enabling patients to find doctors, read other patient opinions and make an appointment online. Based in Poland, it operates websites in 25 countries all over the world. Currently the company has over 200 employees based in offices in Warsaw, Istanbul and Rome. Every month, over 8 million patients visit DocPlanner and search through over 1.4 million listed medical professionals.
Doctoralia is one of the leading platforms in the world connecting healthcare professionals with patients, transforming and improving the relationship between them. Doctoralia offers tools that help to improve the online presence of healthcare professionals, helping them to find more patients and to manage them better. In turn, making healthcare more accessible to patients, offering them a space to ask, review and find the best healthcare professional according to their needs. Doctoralia has 9 million users monthly and is available in 20 countries such as Spain, Brazil, Mexico and Argentina.
Founded in 2012, Target Global is an international VC firm with over $300 million in assets under management and offices in Berlin, Tel Aviv, Moscow and San Francisco. Target Global focuses primarily on fast-growing digital-enabled companies in e-commerce, fintech, travel, SaaS and mobile. It has invested in innovative companies in the USA, Europe and Israel, supporting them with global networks and expertise, particularly in the area of internationalisation. Due to its global platform of four local teams, Target Global is pursuing an international investment strategy, while simultaneously factoring in local market requirements and understanding.
ENERN is a venture capital / private equity group managing €100 million in funds. In consumer internet, ENERN invests into marketplaces, e-commerce, and fintech companies at early and growth stages. It has offices in Prague and Warsaw. More about Enern at: http://www.enern.eu.
The EBRD Venture Capital Investment Programme is a dedicated €100 million capital pool and team investing early and growth stage venture capital in innovative, high-growth technology companies from Central Europe to Central Asia. It focuses on providing active leadership in the development of technology and venture financing ecosystems in its countries of operation. Learn more about the EBRD at http://ebrdvcip.com.